INS and type 2 diabetes mellitus: A third study in 14 patients (9 without T2D and 5 with T2D) showed a significant increase in blood glucose, with no significant changes in plasma insulin levels with the use of empagliflozin 25 mg, an effect attributed to an increase in hepatic glucose production [105].